Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01127932 · ClinicalTrials.gov registry record · NA
Developing an Intervention to Address Suicide Risk During Substance Use Disorder
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01127932: Completed NA study, sponsored by University of Michigan.
NCT01127932 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01127932, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This is a 2-year study designed to: (1) adapt and refine an existing cognitive-behavioral treatment (CBT) intervention to decrease suicidal thoughts and behaviors for use in Substance Use Disorder (SUD) treatment settings, and (2) conduct a pilot randomized controlled trial with 50 patients in treatment for SUDs comparing the CBT intervention to an enhanced control condition. Through this pilot randomized controlled trial, the investigators hope to not only obtain information about the feasibility of implementing these procedures in residential SUD treatment, but to also determine whether this intervention decreases the level of suicidal ideation, suicide attempts, hopelessness, and frequency of substance use relative to the control condition.
Interventions
- BEHAVIORAL Psychoeducation for substance abuse
- BEHAVIORAL CBT for suicide in Substance abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01127932 record still lists
NCT01127932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Psychoeducation for substance abuse is the first listed.
NCT01127932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01127932 about?
NCT01127932 is a clinical study titled "Developing an Intervention to Address Suicide Risk During Substance Use Disorder". This is a 2-year study designed to: (1) adapt and refine an existing cognitive-behavioral treatment (CBT) intervention to decrease suicidal thoughts and behaviors for use in Substance Use Disorder (SUD) treatment settings, and (2) conduct a pilot randomized controlled trial with 50 patients in treat...
What is the current status of trial NCT01127932?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2010-04. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01127932?
The interventions under investigation include: Psychoeducation for substance abuse (BEHAVIORAL), CBT for suicide in Substance abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT01127932?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01127932's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia